• Bauer J, Isojärvi JI, Herzog AG, Reuber M, Polson D, Taubøll E, Genton P, Van Der Ven H, Roesing B, Luef GJ, Galimberti CA, Van Parys J, Flugel D, Bergmann A, Elger CE. (2002) Reproductive dysfunction in women with epilepsy: recommendations for evaluation and management. Journal of Neurology, Neurosurgery, and Psychiatry 73(2):121125.
  • Dana-Haeri J, Trimble M, Oxley J. (1983) Prolactin and gonadotropin changes following generalised and partial seizures. Journal of Neurology, Neurosurgery, and Psychiatry 46:331335.
  • Ferriman D, Gallwey JD. (1961) Clinical assessment of body hair growth in women. Journal of Clinical Endocrinology and Metabolism 21:14401447.
  • Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC Jr, Spertus JA, Costa F. (2005) Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112(17):27352752.
  • Herzog AG. (1993) A relationship between particular reproductive endocrine disorders and the laterality of epileptiform discharges, in women with epilepsy. Neurology 43(10):19071910.
  • Herzog AG. (1997) Disorders of reproduction and fertility. In EngelJ, PedleyTA (Eds) Epilepsy: a comprehensive textbook. Lippincott-Raven, Philadelphia , pp. 20132026.
  • Herzog AG, Seibel MM, Schomer D, Vaitukaitis J, Geschwind N. (1986) Reproductive endocrine disorders in women with partial seizures of temporal lobe origin. Archives of Neurology 43(4):341346.
  • Isojärvi JI, Laatikainen TJ, Knip M, Pakarinen AJ, Juntunen KT, Myllylä VV. (1996) Obesity and endocrine disorders in women taking valproate for epilepsy. Annals of Neurology 39(5):579584.
  • Isojärvi JI, Laatikainen TJ, Pakarinen AJ, Juntunen KT, Myllylä VV. (1993) Polycystic ovaries and hyperandrogenism in women taking valproate for epilepsy. New England Journal of Medicine 329(19):13831388.
  • Isojärvi JI, Taubøll E, Pakarinen AJ, Van Parys J, Rättyä J, Harbo HF, Dale PO, Fauser BC. Gjerstad L, Koivunen R, Knip M, Tapanainen JS. (2001) Altered ovarian function and cardiovascular risk factors in valproate-treated women. American Journal of Medicine 111(4):290296.
  • Luef G, Abraham I, Haslinger M, Trinka E, Seppi K, Unterberger I, Alge A, Windisch J, Lechleitner M, Bauser G. (2002a) Polycystic ovaries, obesity and insulin resistance in women with epilepsy. A comparative study of carbamazepine and valproic acid in 105 women. Journal of Neurology 249(7):835841.
  • Luef G, Abraham I, Hoppichler F, Trinka E, Unterberger I, Bauer G, Lechleitner M. (2002b) Increase in postprandial serum insulin levels in epileptic patients with valproic acid therapy. Metabolism 51(10):12741278.
  • Luef GJ, Lechleitner M, Bauer G, Trinka E, Hengster P. (2003) Valproic acid modulates islet cell insulin secretion: a possible mechanism of weight gain in epilepsy patients. Epilepsy Research 55(1-2):5358.
  • Mikkonen K, Vainionpää LK, Pakarinen AJ, Knip M, Järvelä IY, Tapanainen JS, Isojärvi JI. (2004) Long-term reproductive endocrine health in young women with epilepsy during puberty. Neurology 62(3):445450.
  • Morrell MJ. (2003) Reproductive and metabolic disorders in women with epilepsy. Epilepsia 44(Suppl 4):1120.
  • Morrell MJ, Giudice L, Flynn KL, Seale CG, Paulson AJ, Dne S, Flaster E, Ferin M, Sauer MV. (2002) Predictors of ovulatory failure in women with epilepsy. Annals of Neurology 52(6):704711.
  • Morrell MJ, Isojärvi J, Taylor AE, Dam M, Ayala R, Gomez G, O'Neill F, Tennis P, Messenheimer J. (2003) Higher androgens and weight gain with valproate compared with lamotrigine for epilepsy. Epilepsy Research 54(2-3):189199.
  • Palter SF, Olive DL. (1996) Reproductive physiology. In BerekJS, AdashiEY, HillardPA (Eds) Novak's Gynecology. 12th ed. Williams & Wilkins, Baltimore , pp. 159.
  • Pylvänen V, Knip M, Pakarinen A, Kotila M, Turkka J, Isojärvi JI. (2002) Serum insulin and leptin levels in valproate-associated obesity. Epilepsia 43(5):514517.
  • Pylvänen V, Knip M, Pakarinen AJ, Turkka J, Kotila M, Rattya J, Myllylä VV, Isojärvi JI. (2003) Fasting serum insulin and lipid levels in men with epilepsy. Neurology 60(4):571574.
  • Rättyä J, Pakarinen AJ, Knip M, Repo-Outakoski M, Myllylä VV, Isojärvi JI. (2001) Early hormonal changes during valproate or carbamazepine treatment: a 3-month study. Neurology 57(3):440444.
  • Reilly MP, Wolfe ML, Rhodes T, Girman C, Mehta N, Rader DJ. (2004) Measures of insulin resistance add incremental value to the clinical diagnosis of metabolic syndrome in association with coronary atherosclerosis. Circulation 110(7):803809.
  • Ryu S, Sung KC, Chang Y, Lee WY, Rhee EJ. (2005) Spectrum of insulin sensitivity in the Korean population. Metabolism 54(12):16441651.
  • Verrotti A, Basciani F, De Simone M, Trotta D, Morgese G, Chiarelli F. (2002) Insulin resistance in epileptic girls who gain weight after therapy with valproic acid. Journal of Child Neurology 17(4):265268.